Compound Detail
CHEMBL189565
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL189565 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ZMQJTJNYMBHSHR-MDWZMJQESA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
5
Publications
0
Known Names
Molecular Properties
316.4
MW (Da)
4.82
ALogP
2
HBA
2
HBD
57.5
PSA (Ų)
0.68
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 4.9
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 4.9 | 4.9 | 12500.0 | 1 |
| IGROV-1 CHEMBL613984 | IC50 | 4.72 | 4.72 | 19000.0 | 1 |
| NB-4 CHEMBL614188 | IC50 | 4.34 | 4.34 | 45300.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| NON-PROTEIN TARGET | IC50 | = | 12500.0 | nM | 4.9 | Concentration of compound required for inhibition of (IGROV-1/Pt1) human cisplat... | 16033272 |
| IGROV-1 | IC50 | = | 19000.0 | nM | 4.72 | Concentration of compound required for inhibition of (IGROV-1) human ovarian car... | 16033272 |
| NB-4 | IC50 | = | 45300.0 | nM | 4.34 | Concentration of compound required for inhibition of (NB4) human promyelocytic l... | 16033272 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 16033272 | 10.1021/jm049440h | Unchecked | 3 |
| 16033272 | 10.1021/jm049440h | IGROV-1 | 2 |
| 16033272 | 10.1021/jm049440h | NON-PROTEIN TARGET | 1 |
| 16033272 | 10.1021/jm049440h | NB-4 | 1 |
| 16033272 | 10.1021/jm049440h | Retinoic acid receptor beta | 1 |
Data from ChEMBL 36 via Core Engine